Discovery of P3971 an orally efficacious novel anticancer agent targeting HIF-1α and STAT3 pathways.
Godse P, Kumar P, Yewalkar N, Deore V, Lohar M, Mundada R, Padgaonkar A, Manohar S, Joshi A, Bhatia D, Desai N, Damre A, Bhonde M, Joshi K, Sharma R, Kumar S.
Godse P, et al. Among authors: padgaonkar a.
Anticancer Agents Med Chem. 2013 Nov;13(9):1460-6. doi: 10.2174/18715206113136660341.
Anticancer Agents Med Chem. 2013.
PMID: 24102269